Clinical Trial Update: A Trial to Study the Safety and Efficacy of SM-020 Gel 1.0% in Subjects With Dermatosis Papulosa Nigra (DPN) [Phase 2]

View source ↗

Summary

A Phase 2 study assessing the safety and efficacy of SM-020 Gel 1.0% in Dermatosis Papulosa Nigra, with the trial currently listed as Active Not Recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dermatosis Papulosa Nigra

Drugs mentioned

• SM-020 Gel 1.0% (SM-020)

Snippet

Sponsor: DermBiont, Inc. | Conditions: Dermatosis Papulosa Nigra | Phase 2 | Status: ACTIVE_NOT_RECRUITING